IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,985 | -0.3% | 59 | -10.6% | 0.00% | 0.0% |
| Q3 2023 | $2,994 | +10.6% | 66 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,708 | +22.6% | 66 | +6.5% | 0.00% | 0.0% |
| Q1 2023 | $2,208 | -25.1% | 62 | -20.5% | 0.00% | 0.0% |
| Q4 2022 | $2,946 | -1.8% | 78 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | 0.0% | 78 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | 0.0% | 78 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | +200.0% | 78 | +69.6% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 46 | -13.2% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | 0.0% | 53 | +15.2% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | -66.7% | 46 | -6.1% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | +200.0% | 49 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | 0.0% | 46 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | +100.0% | 46 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 46 | -19.3% | 0.00% | -100.0% |
| Q1 2018 | $2,000 | -77.8% | 57 | -69.4% | 0.00% | -75.0% |
| Q4 2017 | $9,000 | 0.0% | 186 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $9,000 | -10.0% | 186 | -13.9% | 0.01% | -16.7% |
| Q2 2017 | $10,000 | +25.0% | 216 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $8,000 | -20.0% | 216 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $10,000 | +42.9% | 216 | 0.0% | 0.01% | +50.0% |
| Q3 2016 | $7,000 | +40.0% | 216 | -10.7% | 0.00% | +33.3% |
| Q2 2016 | $5,000 | -44.4% | 242 | 0.0% | 0.00% | -40.0% |
| Q1 2016 | $9,000 | -43.8% | 242 | -10.7% | 0.01% | -50.0% |
| Q4 2015 | $16,000 | – | 271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |